GeneDx has announced plans to acquire Fabric Genomics, a company specializing in AI-based genomic interpretation, in a move aimed at expanding the reach and flexibility of clinical genomics. The acquisition, expected to close in Q2 2025, is valued at up to $51 million depending on milestone achievements.
The integration brings together GeneDx’s rare disease dataset—built from over 750,000 exomes and genomes—and Fabric’s cloud-native interpretation platform, which has been deployed across major health systems for…
